Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device

In the fight against COVID-19, there remains an unmet need for point-of-care (POC) diagnostic testing tools that can rapidly and sensitively detect the causative SARS-CoV-2 virus to control disease transmission and improve patient management. Emerging CRISPR-Cas-assisted SARS-CoV-2 detection assays...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fan-En, Lee, Pei-Wei, Trick, Alexander Y., Park, Joon Soo, Chen, Liben, Shah, Kushagra, Mostafa, Heba, Carroll, Karen C., Hsieh, Kuangwen, Wang, Tza-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170879/
https://www.ncbi.nlm.nih.gov/pubmed/34171821
http://dx.doi.org/10.1016/j.bios.2021.113390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170879/
https://www.ncbi.nlm.nih.gov/pubmed/34171821
http://dx.doi.org/10.1016/j.bios.2021.113390

Ejemplares similares